FLC testing in the diagnosis and monitoring of AL amyloidosis

Amyloid light-chain (AL) amyloidosis, or primary amyloidosis, is the most common form of systemic amyloidosis. Abnormal free light chains are the key diagnostic parameter for this rare disease. FLC testing is also essential for the monitoring and management of amyloidosis. In this webinar, Dr. Palladini discusses the key role of FLC testing in the detection and monitoring of amyloidosis and summarizes the results of recent studies.

Giovanni Palladini, Department of Molecular Medicine University of Pavia

Prof. Dr. Giovanni Palladini
Amyloidosis Research and Treatment Center
Fondazione IRCCS Policlinico San Matteo and
Department of Molecular Medicine
University of Pavia, Italy